Higher T2 lesion volume in clinically isolated syndrome indicates higher risk of clinically definite multiple sclerosis

被引：0
|
作者：
Kalincik, T. [1 ]
Vaneckova, M. [1 ]
Krasensky, J. [1 ]
Seidl, Z. [1 ]
Tyblova, M. [1 ]
Volna, J. [1 ]
Havrdova, E. [1 ]
Horakova, D. [1 ]
机构：
[1] Charles Univ Prague, Prague, Czech Republic
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [41] Deep grey matter T2 hypointensity in patients with clinically isolated syndromes suggestive of multiple sclerosis
    Ceccarelli, A.
    Neema, M.
    Rocca, M.
    Healy, B.
    Arora, A.
    Comi, G.
    Bakshi, R.
    Filippi, M.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S96 - S96
  • [42] Mood and coping in clinically isolated syndrome and multiple sclerosis
    Bianchi, V.
    De Giglio, L.
    Prosperini, L.
    Mancinelli, C.
    De Angelis, F.
    Barletta, V.
    Pozzilli, C.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (06): : 374 - 381
  • [43] Clinically isolated syndrome and multiple sclerosis: Rethinking the arsenal
    Pandey, Krupa
    Lublin, Fred D.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2009, 11 (03) : 193 - 202
  • [44] Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis
    Benedetti, Maria Donata
    Filippini, Graziella
    Solari, Alessandra
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (08): : 788 - 789
  • [45] Deep grey matter T2 hypointensity in patients with clinically isolated syndromes suggestive of multiple sclerosis
    Ceccarelli, A.
    Neema, M.
    Rocca, M. A.
    Healey, B. C.
    Arora, A.
    Comi, G.
    Bakshi, R.
    Filippi, M.
    JOURNAL OF NEUROLOGY, 2009, 256 : S203 - S203
  • [46] Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
    Metz, L. M.
    Li, D. K. B.
    Traboulsee, A. L.
    Duquette, P.
    Eliasziw, M.
    Cerchiaro, G.
    Greenfield, J.
    Riddehough, A.
    Yeung, M.
    Kremenchutzky, M.
    Vorobeychik, G.
    Freedman, M. S.
    Bhan, V.
    Blevins, G.
    Marriott, J. J.
    Grand'Maison, F.
    Lee, L.
    Thibault, M.
    Hill, M. D.
    Yong, V. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (22): : 2122 - 2133
  • [47] Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox?
    Strasser-Fuchs, S.
    Enzinger, C.
    Ropele, S.
    Wallner, M.
    Fazekas, F.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (02) : 205 - 211
  • [48] Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome
    Freedman, Mark S.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (06) : 279 - 288
  • [49] Smoking is a risk factor for early conversion to clinically definite multiple sclerosis
    Di Pauli, F.
    Reindl, M.
    Ehling, R.
    Schautzer, F.
    Gneiss, C.
    Lutterotti, A.
    O'Reilly, E. J.
    Munger, K. L.
    Deisenhammer, F.
    Ascherio, A.
    Berger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (08) : 1026 - 1030
  • [50] The comparison of McDonald 2005, McDonald 2010 and Swanton criteria for prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis
    Cinar, B. Piri
    Ozakbas, S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 60 - 60
12345